The evaluation of antirheumatic drugs

1 January 1973

journal article
clinical trial
Published by Taylor & Francis in Current Medical Research and Opinion

Vol. 1 (7) , 427-443
https://doi.org/10.1185/03007997309111705

Abstract

The available methods of evaluation of an antirheumatic compound in a clinical trial situation are discussed. The techniques of single-blind and double-blind studies are described and their respective merits analysed. Proposed new techniques for the measurement of joint inflammation are reviewed.

Keywords

This publication has 47 references indexed in Scilit:

CONTROLLED TRIAL OF D(-)PENICILLAMINE IN SEVERE RHEUMATOID ARTHRITIS
The Lancet, 1973
Comparison of Aspirin and Benorylate in the Treatment of Rheumatoid Arthritis
BMJ, 1972
A Twenty‐Pound Dolorimeter for Quantification of Articular Tenderness
Arthritis & Rheumatism, 1968
Clinical Appraisal of the Activity Index as a Measure of Rheumatoid Activity
Arthritis & Rheumatism, 1968
The estimation of inflammatory activity in rheumatoid arthritis. Role of composite indices
Arthritis & Rheumatism, 1967
Do psyhiatric out-patients take their drugs?
BMJ, 1965
The use of Rating Scales in Clinical Research
The British Journal of Psychiatry, 1965
THE CLINICAL MEASUREMENT OF PAIN
Annals of the New York Academy of Sciences, 1960
A Comparison of Cortisone and Aspirin in the Treatment of Early Cases of Rheumatoid Arthritis
BMJ, 1955
Cortisone and Other Steroids in Rheumatoid Arthritis
BMJ, 1950